Castellum, Inc. (NYSEAMERICAN:CTM – Get Free Report) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 332,300 shares, a growth of 228.7% from the October 31st total of 101,100 shares. Approximately 1.1% of the company’s shares are short sold. Based on an average daily volume of 1,470,000 shares, the short-interest ratio is presently 0.2 days.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Castellum stock. Virtu Financial LLC lifted its stake in Castellum, Inc. (NYSEAMERICAN:CTM – Free Report) by 82.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 103,288 shares of the company’s stock after buying an additional 46,606 shares during the period. Virtu Financial LLC owned about 0.19% of Castellum worth $27,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 3.39% of the company’s stock.
Castellum Stock Performance
NYSEAMERICAN:CTM traded up $0.02 during midday trading on Wednesday, reaching $0.19. 1,148,011 shares of the company traded hands, compared to its average volume of 863,702. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 1.11. Castellum has a twelve month low of $0.12 and a twelve month high of $0.40.
About Castellum
Castellum, Inc provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. Its services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model based systems engineering services.
Recommended Stories
- Five stocks we like better than Castellum
- What is the Dogs of the Dow Strategy? Overview and Examples
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What are earnings reports?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Castellum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castellum and related companies with MarketBeat.com's FREE daily email newsletter.